BellBrook Labs- Screening Tools for the Pharmaceutical Industry
BellBrook Labs is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies.
As a small, R&D-driven company, Bell Brook Labs identify areas where there is a strong need but a significant technical hurdle, and then we develop a solution. BellBrook is focused on taking creative approaches to new product development and to continually improving the level of service provided to our customers. When you communicate with someone from BellBrook it will be immediately apparent that they share your passion for discovering more effective disease therapies and your respect for the complexity of biology.
BellBrook Labs specializes in two major technology platforms-
Transcreener® Biochemical Assay Technology:
Universal, high throughput screening platform for enzymes based on direct detection of nucleotide enzyme products with far red FI, FP and TR-FRET readouts. Transcreener assays enable you to screen more targets, both well characterized and emerging, faster and more efficiently.
• Four assays cover thousands of target enzymes, including any kinase, ATPase, or GTPase.
• Direct detection means less chance for compound interference.
• Far Red FP, FI and TR-FRET readouts validated on major multimode readers.
• Single step, mix and read format with 8 hour deck and signal stability for easy automation.